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Gliotoxin is an epipolythiodioxopiperazine (ETP) class toxin, contains a disul-
fide bridge that mediates its toxic effects via redox cycling and is produced
by the opportunistic fungal pathogen Aspergillus fumigatus. Self-resistance
against gliotoxin is effected by the gliotoxin oxidase GliT, and attenuation of
gliotoxin biosynthesis is catalysed by gliotoxin S-methyltransferase GtmA.
Here we describe the X-ray crystal structures of GtmA-apo (1.66 A˚), GtmA
complexed to S-adenosylhomocysteine (1.33 A˚) and GtmA complexed to
S-adenosylmethionine (2.28 A˚), providingmechanistic insights into this impor-
tant biotransformation. We further reveal that simultaneous elimination of the
ability of A. fumigatus to dissipate highly reactive dithiol gliotoxin, via deletion
of GliT andGtmA, results in themost significant hypersensitivity to exogenous
gliotoxin observed to date. Indeed, quantitative proteomic analysis of
DgliT::DgtmA reveals an uncontrolled over-activation of the gli-cluster upon
gliotoxin exposure. The data presented herein reveal, for the first time, the
extreme risk associated with intracellular dithiol gliotoxin biosynthesis—in
the absence of an efficient dismutation capacity. Significantly, a previously con-
cealed protective role for GtmAand functionality of ETP bis-thiomethylation as
an ancestral protection strategy against dithiol compounds is now evident.1. Introduction
Ascomycetes constitute the largest phylum of the fungal kingdom and produce a
copious array of natural products. Although many of these compounds are
known as clinically important drugs or industrial chemicals, several natural pro-
ducts are potent toxins that pose substantial threats to human food supplies and
health [1]. Production of these natural products requires a carefully orchestrated
system to balance biosynthesis while avoiding self-harm from endogenous
accumulation of toxic natural product precursors [2].
Epipolythiodioxopiperazine (ETP) alkaloids are toxic natural products
characterized by a unique bridged disulfide or polysulfide dioxopiperazine
ring. Gliotoxin, produced by the opportunistic fungus Aspergillus fumigatus, is
the prototypic member of this large family [3]. As with other ETPs, gliotoxin is
produced through a sequential series of enzymatic steps which are organized
into a coordinated biosynthetic gene cluster (figure 1). Although the mechanism
of action for the cytotoxicity of gliotoxin has not been fully elucidated, two pri-
mary activities have been described: the generation of reactive oxygen species
(ROS) through oxidation of the disulfide bridge and mixed disulfide formation.
The stereochemically complex core of ETPs, coupled with their potent biological
activities, make these compounds an attractive target for drug leads [7].
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Figure 1. Conversion of gliotoxin between the reduced (dithiol gliotoxin), oxidized (gliotoxin) and bisthiomethyl forms. In A. fumigatus, the gli-cluster that encodes
gliotoxin biosynthesis consists of 13 genes (in colour and labelled with their last letter) and is located on chromosome 6 [4–6]. gtmA is encoded outside the cluster
and is on chromosome 2.
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2Resistance genes are required to allow a toxin producer to
grow in the presence of its own metabolic weaponry, and
ETPs are no exception to this rule [8]. Indeed, one of the
genes in the gliotoxin biosynthetic gene cluster in A. fumigatus,
gliT, gliotoxin oxidase, is required for self-protection against
the toxin [4,9]. Deletion of this gene renders A. fumigatus sensi-
tive to exogenous gliotoxin. Enzyme-catalysed epidisulfide
formation appears to be restricted to ETP producers, despite
the fact that heterologous expression of GliT in A. nidulans
or Saccharomyces cerevisiae provided effective cross-species
resistance to gliotoxin [4].
Several fungi have been shown to carry out an irreversible
enzymatic bis-thiomethylation of these disulfide-containing
metabolites. These S-methylated ETP derivatives have a
significantly dulled bioactivity. S-methylation of dithiol metab-
olites also extends to bacteria, and Streptomyces clavuligerus
has been shown to produce a bis-thiomethylated derivative
of the dithiolpyrrolone antibiotic holomycin [10]. This thio-
methylation mechanism has been posited as an additional or
backup strategy to disulfide bridge closure for self-protection
during holomycin biosynthesis. It has been proposed that
S-methylation of biosynthetic intermediates or possibly shunt
metabolites protect cellular components against these reactive
species [10,11].
We and others have shown that A. fumigatus effects dithiol
gliotoxin S-methylation via a methyltransferase, gliotoxin
thiomethyltransferase A (GtmA or TmtA) located outside the
gliotoxin gene cluster [12,13]. Deletion of gtmA resulted in no
additional sensitivity to exogenous gliotoxin [12], but comple-
tely abrogated bis(methyl)gliotoxin (BmGT) production in this
organism. This led us to conclude that GtmA is not primarily
involved in the detoxification of gliotoxin or related biosyn-
thetic intermediates [14] as has been previously proposed
[10]. We subsequently demonstrated that GtmA-mediated
bis-thiomethylation of gliotoxin by A. fumigatus regulates the
production of this toxin in A. fumigatus by disrupting a posi-
tive feedback loop which normally potentiates gliotoxin
biosynthesis [12].
Are non-ETP producers capable of protecting themselves
against these potent natural products? Recently, it was shown
that disruption of the uncharacterized methyltransferaseMT-II in A. niger resulted in increased sensitivity to exogen-
ous gliotoxin. Like GtmA, recombinantly expressed MT-II
was shown to sequentially bis-thiomethylate dithiol gliotoxin,
forming monomethylgliotoxin (MmGT) and then BmGT [15].
MT-II is an orthologue of GtmA (53% sequence identity),
despite the fact that this organism does not produce glio-
toxin. This suggested that bis-thiomethylation may have
an ancestral role in protecting organisms against dithiol-
containing toxins in selected filamentous fungi, such as
A. niger and A. nidulans [13,15]. However, it appears that
ETP self-protection in producer organisms is dominated by
reversible enzyme-catalysed epidisulfide formation, whereas
the permanent, metabolically expensive mechanism of
ETP S-methylation has become specialized to regulate ETP
production in filamentous fungi [12].
We report crystal structures of apo-, SAM- and SAH-
bound GtmA, offering further mechanistic insights into this
elusive biochemical transformation. The presence of a domi-
nant gliotoxin self-protection mechanism in A. fumigatus
(GliT) hinders our understanding of the contribution of ETP
bis-thiomethylation to self-protection. Here, we demonstrate
that a double deletion mutant of gliT and gtmA struggles to
grow in the presence of low amounts of exogenous gliotoxin.
Using quantitative proteomics and metabolomics, we also
demonstrate that the inability to derivatize gliotoxin results
in an unhindered upregulation of the gliotoxin biosynthetic
pathway in this organism—leading to hypersensitivity.2. Results
2.1. Comparison of apo-, SAM- and SAH-complexed
GtmA
In order to obtain detailed insights into the enzymatic mechan-
ism of GtmA-catalysed methyltransfer, we crystallized GtmA
in the cofactor-free form and in complex with SAM and SAH,
and refined the structures at 1.66 A˚, 2.28 A˚ and 1.33 A˚ resol-
ution with R-factors of Rapo ¼ 16.8, RSAM ¼ 19.2, RSAH ¼ 13.9,
and Rfree-values of Rfreeapo ¼ 18.6, RfreeSAM ¼ 23.4, RfreeSAM ¼
16.6, respectively (electronic supplementary material, table S1
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Figure 2. Comparison of apo-GtmA and the SAH/SAM complexes. (a) apo- and
SAH-bound GtmA. The missing secondary structure elements of apo GtmA are
labelled. (b) SAH- and SAM-bound complex. The dramatic movement of the
lower domain and helix a1 is indicated by arrows. (c) Co-factor binding: compari-
son of SAH (magenta) and SAM (yellow) binding mode. Thr27, Ala54, Asp82 and
Asn109 are similar in position, only Tyr20 is flipped out in the SAM structure owing
to the movement of the lower domain and helix a1. (d ) Comparison of apo-
(cyan) and SAH-complexed (magenta) GtmA. The disulfide bridge found between
Cys55 and Cys80 of the apo structure has to be reduced to allow SAH/SAM binding.
(e) Asn159 is involved in a hydrogen bonding network with Asn161, Glu182, a
Naþ cation, a water molecule and Trp162. (f ) Disruption of the GT binding
pocket in the SAM complex. The SAH complex is coloured magenta and the
SAM complex yellow. Also see electronic supplementary material, figure S5.
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3and S2). Despite multiple attempts, we were unable to obtain
cocrystals of GtmAwith either gliotoxin or BmGT bound. The
apo form crystallized in space group P62 with one chain in
the asymmetric unit, whereas the complexes appeared in two
different crystal forms belonging to space group P21 with two
monomers as the asymmetric unit in both cases. According to
PDBePISA [16], the SAH-complexed GtmA forms a stable
dimer, as indicated by a buried surface area of 3450 A˚2 of
22 640 A˚2 total surface area and a solvation free energy gain
of281.3 kcal mol21. However, althoughmany natural product
methyltransferases are dimeric [17], GtmA appeared to be
monomeric during size exclusion chromatography (electronic
supplementary material, figure S1). Furthermore, the dimeric
arrangement of the SAH complex was not observed in the
apo- or SAM-complexed structure, where dimeric arrange-
ments are established via different interfaces (electronic
supplementary material, figure S1). Therefore, the dimer
found in the SAH complex is probably a crystallization artefact.
Electronic supplementary material, figure S2 shows electron
densities of SAM and SAH.
GtmA consists of two domains, a larger ‘upper’ domain
containing a Rossmann-fold involved in binding the co-
substrate SAM and a smaller ‘lower’ domain that changes its
relative position to the upper domain in the three crystal struc-
tures described here (figure 2a,b). apo-GtmA seems to be
highly flexible, as indicated by the higher B-factors. The flexi-
bility is more pronounced in the lower domain, which is also
evident by the finding that almost no ordered water molecules
can be observed in the electron density of this region. The apo
structure adopts a similar conformation as the SAH complex;
however, parts of the upper domain (the first 22 residues of
the N-terminus including parts of a1 and residues 86–114,
including the complete secondary structure elements b3 and
a4), are not visible in the electron density (figure 2a). On the
other hand, our SAH- and SAM-bound structures show
some striking differences. Whereas the upper domain is
almost identical, the lower domain and helix a1 are twisted
by 878 [18] in the SAM-bound structure. This movement is
mediated by the three linker strands b5–7 (figure 2a), and
even though the lower domain is involved in crystal contacts,
its movement does not seem to be caused by crystallization
because it affects both independent monomers in the asym-
metric unit to the same extent and was observed only when
crystals were grown in the presence of SAM (electronic sup-
plementary material, figure S1). We therefore hypothesize
that this conformation represents an intermediate state of
GtmA during the methyltransferase reaction cycle. In agree-
ment with Duell et al. [19], who have recently published the
structure of a GtmA–SAH complex in the same crystal form
as described here, the cofactor binding site of GtmA is located
in the upper part of a cleft between the two domains built by
helix a1, sheet b2 and loop regions connecting b1–a2 and b3–
b4 (figure 2a). The carboxylate group of SAH is hydrogen
bonded to Thr27 and Tyr20, residues located in helix a1. How-
ever, in the SAM-bound structure, Tyr20 is flipped out of the
binding site. The adenyl component of the cofactor is bound
to Asn109, the amino group interacts with the backbone carbo-
nyl atom of Ala54, and the ribose hydroxyl moiety is fixed by
Asp82 (figure 2c,d).
Interestingly, the two important residues Ala54 and Asp82
are part of b-strands b1 and b2, two regions connected by a di-
sulfide bridge formed by Cys55 and Cys80 in the apo structure
(figure 2c,d). This disulfide bridge appears to be reduced in the
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Figure 3. (a) RP-HPLC chromatograms of GtmA wild-type, GtmA W157V, GtmA W162V, GtmA N159V, GtmA F185G, GtmA F127V and a ‘no GtmA’ control incubated
with dithiol gliotoxin and SAM. Dithiol gliotoxin (green), mono(methylthio)gliotoxin (orange), bis(methyl)gliotoxin (red). (b) GtmA Km determination for dithiol
gliotoxin (rGT; 38.62 mM) was almost fivefold lower than that for purified MmGT (184.5 mM). (c) GtmA-mediated bis-thiomethylation occurs sequentially. The
addition of increasing amounts of SAM (100–400 mM) results in the increased formation of bis(methyl)gliotoxin (red) compared with monomethylgliotoxin
(orange). Dithiol gliotoxin is shown in green.
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4cofactor-bound structures, leading to a movement of the two
b-strands towards the cofactor. This motion is a prerequisite
to provide the corresponding interaction partners for the bind-
ing of the co-substrate SAM (figure 2b). We investigated the
possible relevance of the disulfide bridge by carrying out
microscale thermophoresis (MST) to determine the affinity of
GtmA for SAMunder reducing and oxidizing conditions; how-
ever, the affinity of GtmA for SAM was similar in both cases
(electronic supplementary material, figure S3).
A sequence alignment of A. fumigatus GtmA with the
A. niger GtmA homologue MT-II indicated residues that have
a high degree of conservation [20]. Considering both these
methyltransferases catalyse the same reaction, residues which
are essential for controlling substrate specificity or catalysis
are likely to be conserved. In combination with the crystallo-
graphic data shown in figure 2, the five residues W157V,
W162V, N159V, F185G and F127V (electronic supplementary
material, figure S4) were selected for mutagenesis. These resi-
dues are identical in A. fumigatus GtmA and A. niger MT-II
(electronic supplementary material, figure S6). As shown in
figure 3a, methyltransferase activity of the GtmA mutants
was monitored by RP-HPLC. Wild-type GtmA converted all
dithiol gliotoxin in the reaction (green) to BmGT (red).
We found that the Asn159Val mutant generated only low
levels of MmGT and BmGT compared with the wild-type
enzyme, which might be caused by a disturbed release of the
monomethylated form. Asn159 is located at the surface of the
apo- and SAH-complexed GtmA, and did not seem to interact
with residues putatively involved in dithiol gliotoxin binding
or methyltransfer. However, in the SAM complex, it is part of
a hydrogen bonding network with Asn161, Gln182, a sodium
ion, a water molecule and Trp162 (figure 2c). Trp162 itself
was shown to be crucial for efficient catalysis (figure 3a). This
network of hydrogen bonds only appears in the SAM complex
and emerges from the large structural movement of the lowerdomain. Compared with the closed apo- and the SAH-bound
structures, this complex is elongated and open, such that the
cofactor binding pocket appears accessible (figure 2e,f) and
the putative dithiol gliotoxin binding site predicted by Duell
et al. [19] by molecular docking (comprising W162, Y20, F11,
T27, M10, F185) is disrupted (figure 2c; electronic supple-
mentary material, figure S5). Therefore, we propose that the
SAM complex observed in our data represents the state
before dithiol gliotoxin binds. Further, we hypothesize that
the lower domain functions as a carrier that locates the sub-
strate to its proper position and thereby closes the active site.
After the first methyltransfer, the lower domain moves back
to the position found in the SAM complex, SAH is exchanged
for SAM and the second methylation can occur in the closed
state. This conformational change is impaired in the
Asn159Val variant, leading to a disturbed release mechanism
and to the production of lower levels of MmGT and BmGT.
Trp157Val and Trp162Val had a significant effect on the
activity of the enzyme as these residues have been proposed
to stabilize the diketopiperazine core of dithiol gliotoxin [19].
The conversion of dithiol gliotoxin to BmGT is significantly
diminished when the Trp157Val mutant is used to effect
catalysis (figure 3a). Almost no BmGT is generated by this
enzyme, and only low quantities of MmGT are apparent.
Phe127Val also resulted in a significant decrease in GtmA
activity.
2.2. Mechanistic insights into GtmA activity
Considering that GtmA is the first methyltransferase identi-
fied with dual ETP S-methylation activity, mechanistic and
structural insight into the process of GtmA substrate binding
and the methylation sequence is of considerable interest. The
GtmA Km determined for dithiol gliotoxin (38.62 mM) was
almost fivefold lower than that for purified MmGT (184.5 mM;
WT26933
DgtmA
DgliT
DgliT::DgtmA
DgliA::DgtmA
DgliA
0 2.5 5 10 20
GT (mg ml–1)
Figure 4. (a) Deletion of gtmA does not result in gliotoxin sensitivity when
compared with A. fumigatus wild-type. Deletion of gtmA in the gliotoxin-sen-
sitive strains DgliT and DgliA resulted in double mutants with an increased
sensitivity to gliotoxin exposure. Aspergillus fumigatus DgliT::DgtmA was
shown to be particularly sensitive to exogenous gliotoxin whereby the
radial growth of this mutant was inhibited at 2.5 mg ml21 gliotoxin.
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5figure 3b), which suggests the former is the preferred substrate
for the enzyme. Moreover, time-course analysis of GtmA
activity over 60 min revealed that almost 50% of added dithiol
gliotoxin is converted toMmGT by 20 min, prior to commence-
ment of detectable BmGT formation (electronic supplementary
material, figure S7). As shown in figure 3c, the conversion of
dithiol gliotoxin to MmGT/BmGT by GtmA was also moni-
tored under SAM-limiting conditions. MmGT is detected as
the primary reaction product when SAM is limiting in the
methyltransfer reaction (100–200 mM), and BmGT appears to
only be generated following the conversion of dithiol gliotoxin
to MmGT. Adding additional SAM to the SAM-limited reac-
tions resulted in full conversion of the MmGT to BmGT, thus
proving that GtmA can bind to free MmGT (electronic sup-
plementary material, figure S7). This suggests that after the
first S-methylation, MmGT leaves the GtmA complex and is
then taken up for methylation on the opposite thiol by a
second GtmA molecule with SAM bound. Based on these
data, it appears that GtmA has higher affinity for dithiol
gliotoxin than for MmGT, resulting in the preferential modifi-
cation of dithiol gliotoxin to MmGT before the S-methylation
of MmGT in the second position. The fact that GtmA does
not appear to hold its substrate bound for a secondmethylation
suggests that GtmA is not a processive enzyme, unlike pre-
viously characterized natural product methyltransferases
which mediate consecutive methyltransfers [21].
2.3. GtmA is not subject to SAH-mediated feedback
inhibition
The majority of SAM-dependent methyltransferases are
known to be inhibited by SAH, the methyl-depleted version
of SAM [22]. Recombinant GtmA was pre-incubated with
SAH for 30 min (400 mM) to determine if this metabolite
had an inhibitory effect on bis-thiomethylation activity.
No significant difference in BmGT production was noted in
samples containing SAH or control samples as detected by
RP-HPLC (electronic supplementary material, figure S8).
These results suggest that GtmA was resistant to SAH-
mediated feedback inhibition, indicating a low affinity of
GtmA towards SAH. This is in line with the proposal that
SAH has to be released so that GtmA can undertake a new
methyltransfer reaction.
2.4. The Aspergillus fumigatus double mutants
DgliT::DgtmA and DgliA::DgtmA exhibit
decreased growth upon gliotoxin exposure
Expression of the A. fumigatus dithiol oxidase gene gliT is
required for self-protection against the gliotoxin [4,9]. Simi-
larly, expression of gliA, a major facility superfamily
transporter encoded within the gli-cluster, is also required
for tolerance to gliotoxin [23]. Expression of gtmA was dis-
rupted in the gliotoxin-sensitive ATCC26933 backgrounds
DgliT and DgliA (resulting in DgliT::DgtmA and DgliA::DgtmA)
for comparison with the DgtmA mutant (electronic
supplementary material, figure S9–S11). Plate assays were
performed on Czapek Dox agar containing gliotoxin
(0–20 mg ml21) to determine the response of both
DgliT::DgtmA and DgliA::DgtmA to exogenous gliotoxin
exposure. Radial growth was observed at 24 h time points,and the plates were imaged at 72 h (figure 4). Upon exposure
to gliotoxin, both A. fumigatus DgliT::DgtmA ( p, 0.0001) and
DgliA::DgtmA ( p, 0.0021) exhibited significantly decreased
growth in comparison with their single-deletion counter-
parts. Specifically, DgliT::DgtmA was extremely sensitive to
exogenous gliotoxin exposure.
2.5. Deletion of gtmA in DgliT relieves cellular SAM
depletion following gliotoxin exposure
Considering that we previously suggested a role for
SAM:SAH deregulation in the increased sensitivity of DgliT
to gliotoxin [24], the cellular levels of SAM were evaluated
in DgliT::DgtmA upon gliotoxin exposure compared with a
solvent control. As revealed in figure 5a, the comparison of
cellular SAM levels across the gli-cluster deletion strains
revealed a close link between GtmA activity and cellular
SAM availability following gliotoxin exposure. DgtmA exhib-
ited significantly (p ¼ 0.0021) higher cellular SAM levels
compared with the wild-type strain after gliotoxin exposure,
which is probably due to the absence of bis-thiomethylation.
SAM levels were restored to those of wild-type in gtmAC.
Notably, the severe SAM depletion which was identified in
DgliT following gliotoxin exposure ( p ¼ 0.0001) was alle-
viated in DgliT::DgtmA. Aspergillus fumigatus DgliA::DgtmA
was also shown to retain higher levels of cellular SAM than
DgliA following gliotoxin exposure; however, this was not
as drastic as the changes seen in DgliT compared with
DgliT::DgtmA. The corresponding LC–MS chromatograms
are shown in electronic supplementary material, figure S12.
These results directly link GtmA-mediated bis-thiomethyla-
tion activity and SAM utilization in A. fumigatus and
strongly suggest that the sensitivity of DgliT::DgtmA to glio-
toxin was not primarily due to the deregulation of SAM:SAH.
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Figure 5. (a) SAM detection in A. fumigatus wild-type and selected mutants after 21 h growth in Czapek Dox liquid medium followed by 3 h exposure to
control (MeOH) or gliotoxin exposure (5 mg ml21 final). Compared with the wild-type, significantly higher cellular SAM was detectable in DgliT ( p ¼
0.0093), DgliA ( p ¼ 0.0003), DgliT::DgtmA ( p ¼ 0.0003) and DgliA::DgtmA ( p ¼ 0.0021). Gliotoxin exposure results in highly significant SAM depletion in
DgliT ( p ¼ 0.0001). This SAM depletion does not occur in the DgliT::DgtmA mutant. SAM levels were also significantly reduced in DgliA upon gliotoxin exposure
( p ¼ 0.0100). In comparison, this reduction was not significant in the DgliA::DgtmA double mutant. SAM depletion did not occur in DgtmA to the same degree as
in the wild-type or complemented strain ( p ¼ 0.0021). (b) Exposure of wild-type and mutant strains to 2.5 mg ml21 gliotoxin for 3 h and quantification of the
remaining GT/BmGT in the organically extracted supernatants. The bars represent the combined intensity of GT/BmGT signal on the RP-HPLC 280 nm chromatogram.
Aspergillus fumigatus DgliT::DgtmA has significantly lower extracellular GT/BmGT than DgliT after 3 h ( p ¼ 0.0118).
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62.6. Label-free quantitative proteomic analysis of
Aspergillus fumigatus wild-type, DgtmA, DgliT
and DgliT::DgtmA exposed to gliotoxin
Gliotoxin sensitivity assays (figure 4) demonstrated that
DgliT::DgtmA is extremely sensitive to exogenous gliotoxin but,
unlike A. fumigatus DgliT, this mutant did not undergo SAM
depletion following gliotoxin exposure (figure 5a). In order to
examine the extreme gliotoxin sensitivity of DgliT::DgtmA com-
pared with the response of the single mutants DgliT and
DgtmA, the proteomic signature of A. fumigatus wild-type and
these mutants in response to either gliotoxin (2.5 mg ml21, 3 h)
or a solvent control was characterized. As shown in table 1,
between 2375 and 2512 proteins were detected (triplicate)
across all samples. This allowed us to directly compare the indi-
vidual response of each strain togliotoxin exposure.As shown in
table 1, the number of proteins deregulated in abundance upon
gliotoxin exposure correlatedwith the sensitivity of these strains
to the toxin. Aspergillus fumigatus wild-type and DgtmA, which
are not inhibited by exposure to 2.5 mg ml21 gliotoxin, showed
a total of 168 (wild-type) and 147 (DgtmA) proteins altered in
abundance.Aspergillus fumigatusDgliT,which ismoderatelysen-
sitive to 2.5 mg ml21 gliotoxin, showed a total of 416 proteins
altered in abundance. The highly gliotoxin-sensitive
DgliT::DgtmA showed a total of 548 proteins significantly altered
in abundance upon gliotoxin exposure (electronicsupplementary material, table S3 and figures S13–S18). This
result highlighted that a drastic proteomic remodelling occurs
in DgliT::DgtmA in response to this toxin.
The DgliT versus DgliT::DgtmA LFQ proteomic analysis
samples exposed to gliotoxin were directly compared in order
to elucidate the reasonbehind the enhancedgliotoxin sensitivity
of DgliT::DgtmA. Twenty-four proteins were uniquely detected
in the DgliT::DgtmA under gliotoxin exposure, and 37 proteins
were significantly more abundant in this mutant. Twelve pro-
teins were uniquely detected in DgliT, and 22 proteins were
shown to be significantly more abundant in this mutant com-
pared with DgliT::DgtmA (electronic supplementary material,
table S3 and figures S13–S18).
As shown in table 2, theproteinsmost significantly increased
in abundance in DgliT::DgtmA compared with either DgliT or
DgtmA upon gliotoxin exposure are encoded by the gliotoxin
biosynthetic cluster. Several proteins detected as significantly
less abundant in DgliT::DgtmA were shown to be associa-
ted with the ribosome (electronic supplementary material,
table S3). In line with the sensitivity of this mutant, a hypoxia-
repressed protein (AFUA_2G15290;  21.58155) with a
glutathione-dependent formaldehyde-activating enzyme
domain was significantly less abundant in this mutant. A pre-
dicted homocysteine S-methyltransferase (AFUA_3G01329)
was uniquely detected in DgliT. This proteinmay be specifically
upregulated in DgliT to counteract the homocysteine generated
from BmGT generation.
Table 1. Proteomic analysis of selected A. fumigatus mutants exposed to gliotoxin (2.5 mg ml21) or a solvent (MeOH) control. The quantity of proteins
deregulated in abundance upon gliotoxin exposure correlates with the sensitivity of these mutants to gliotoxin.
condition
total proteins
detected
higher
abundance
(1)
uniquely
detected
lower
abundance
(2)
below
detection limit
Wild-type GT versus MeOH 2512 79 4 45 40
DgtmA GT versus MeOH 2505 101 5 16 25
DgliT GT versus MeOH 2472 211 6 157 42
DgliT::DgtmA GT versus MeOH 2449 274 9 231 34
DgliT versus DgliT::DgtmA GT 2375 29 8 18 9
DgliT versus DgliT::DgtmA MeOH 2487 1 4 6 13
Table 2. Top five proteins with increased abundance in A. fumigatus DgliT::DgtmA compared with DgliT following a 3 h exposure to gliotoxin (2.5 mg ml21).
Data sorted by fold change, in descending order.
protein description
log2(fold
increase) peptides
sequence
coverage (%) protein IDs
glutathione S-transferase encoded in the gliotoxin biosynthetic gene
cluster, GliG
4.12873 10 61.2 AFUA_6G09690
N methyltransferase, encoded in the putative gliotoxin biosynthetic gene
cluster, GliN
3.02483 19 89 AFUA_6G09720
conserved hypothetical protein, encoded in the putative gliotoxin
biosynthetic gene cluster, GliH
2.86394 5 30.7 AFUA_6G09745
predicted O-methyltransferase, encoded in the putative gliotoxin
biosynthetic gene cluster, GliM
2.78612 23 76.1 AFUA_6G09680
glutamyl-tRNA(Gln) amidotransferase, subunit A 2.16436 6 15.9 AFUB_092380
D-3-phosphoglycerate dehydrogenase, role in L-serine biosynthetic process 2.14692 13 34.2 AFUA_2G04490
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72.7. Gliotoxin uptake is enhanced in DgliT::DgtmA
compared with wild-type, DgliT or DgtmA
following gliotoxin exposure
In the absence of GliT,A. fumigatus is unable to export gliotoxin
and consequently unable to protect itself upon exposure. This
suggests that GliA-mediated gliotoxin efflux is specific for
the disulfide form of gliotoxin and that the dithiol form
cannot be secreted. Based on this knowledge, we considered
that DgliT::DgtmA may accumulate significantly more intra-
cellular gliotoxin compared with DgliT. This would be due to
the fact that GliA-mediated gliotoxin efflux is disabled in the
absence of the gliotoxin oxidoreductase GliT [24]. The conco-
mitant disruption of GtmA in this background may result in
a combined inability to dissipate dithiol gliotoxin as BmGT,
which would explain the high sensitivity of this double
mutant to exogenous gliotoxin exposure. The detectable
levels of extracellular gliotoxin and BmGT (GT/BmGT) in cul-
ture supernatants following 3 h gliotoxin exposure
(2.5 mg ml21) was measured across selected A. fumigatus
mutants by RP-HPLC to observe if this correlated with the
level of gliotoxin sensitivity (figure 5b). Notably, DgliT::DgtmA
has significantly lower extracellular GT/BmGT thanDgliT after3 h ( p ¼ 0.0118). This strongly suggests that gliotoxin is
accumulating intracellularly in this mutant at a higher level
than DgliT, resulting in high sensitivity to this toxin.2.8. Confocal microscopy reveals that GtmA-eGFP
is localized throughout the cytosol following
gliotoxin exposure
GliT::eGFP was previously shown to be localized in the
cytoplasm and nuclei of A. fumigatus, supporting its role in
protection against gliotoxin toxicity [4]. Construction of
A. fumigatus GtmA::eGFP, which was also transformed with
histone 2A monomeric red fluorescent protein fusion
(H2A::mRFP) to visualize the nuclei, was undertaken (electro-
nic supplementary material, figures S19 and S20). Confocal
microscopy revealed that GtmA::eGFP accumulates in the cyto-
sol ofA. fumigatus following gliotoxin exposure (5 mg ml21, 3 h;
electronic supplementary material, figure S21). No eGFP signal
was detectable in either the methanol control or the DgtmA
strain exposed to gliotoxin. Cytosolic localization is a feature
of methyltransferases involved in the detoxification of thiol
compounds in other organisms. The thiol methyltransferase
rsob.royalsociet
8from Euglena gracilis [25] and the methyl chloride transferase
from E. muricata [26] are also localized in the cytosol. The
cytosolic location of these enzymes presumably allows
for rapid substrate access. In contrast, the fungal methyl chlor-
ide transferase, which is not involved in detoxification, is
membrane-bound [27].ypublishing.org
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Herein,we reveal detailed structural,mechanistic and functional
insights into GtmA-mediated gliotoxin bis-thiomethylation
and reveal hitherto occluded roles of this enzymatic process,
whereby it functions with GliT to dissipate dithiol gliotoxin
in A. fumigatus. Structures of apo-GtmA, GtmA–SAH and
GtmA–SAM in combination with activity assays provide
new insights into this transformation. The deletion of gtmA
in the A. fumigatus mutant backgrounds DgliT and DgliA
uniquely reveals the consequence, and metabolic impact, of
an uncontrolled dithiol gliotoxin biosynthetic capacity. For
the first time, it is clear that both GtmA and GliT are necessary
to prevent the deleterious effects of dithiol gliotoxin in an ETP
producer.
Our data suggest that GtmAmethylates dithiol gliotoxin by
a non-processive mechanism. Examples of natural product
methyltransferases that processively di- or trimethylate an
acceptor substrate have recently been described. The ergothio-
neine biosynthetic methyltransferase EgtD catalyses three
consecutive methyltransfers to the a-amino group of histidine.
EgtD processivity is a result of increased affinity for the methyl-
ated intermediates, rather than increased catalytic efficiency of
the second and third methylation steps [21]. Similarly, an itera-
tiveO-methyltransferase (FtpM) was recently shown to catalyse
1,11-dimethylation of A. fumigatus fumaric acid amides. No
monomethylated derivatives were detectable in the conditions
tested [28]. BamL, which dimethylates the N-terminus of PZN,
does not release monomethylPZN during the reaction. How-
ever, following mutagenesis of Tyr182Phe in BamL, the
enzyme primarily yields a monomethylated product instead
of the dimethylated product [29].
The homodimeric N,N-dimethyltransferases Tylm1 and
DesVI involved in the biosynthesis of the sugars mycaminose
and desosamine appear to be the only other examples in the
literature of non-processive, sequential natural product
methyltransferases [30]. Chen et al. [30] state that the mono-
methylated intermediate is not an aberrant shunt product
prematurely leaking from the enzyme active site, but a true
intermediate during catalysis. Similar to our proposed reac-
tion mechanism for GtmA, both the monomethylated
intermediate and SAH are released from the active site of
Tylm1 and DesVI following the first methylation reaction.
Subsequent binding of another SAM cofactor and the mono-
methylated intermediate leads to the final product [31]. The
proposed reaction mechanism is consistent with the finding
that GtmA can bind SAM in the absence of its substrate
dithiol gliotoxin. A key difference between GtmA and
Tylm1 is that little monomethylated product accumulates in
the Tylm1 reaction as the second methylation has a consider-
ably greater reaction rate than the first [30]. In contrast, GtmA
appears to preferentially methylate dithiol gliotoxin over the
monomethylated intermediate (figure 3a,b).
We hypothesized that the lack of processivity may be
rooted in the way GtmA deals with SAM/SAH. In order toinvestigate possible structural rearrangements and gain
mechanistic insights into this transformation, we structurally
elucidated the GtmA-apo, GtmA–SAM and GtmA–SAH-
bound structures. These structures revealed several flexible
parts of the upper domain (a1, a4 andb3) which are not visible
in the electron density of the apo structure. This is probably a
consequence of the dynamic nature of GtmA. The central
region forms a helical-lid-like structure near the putative
active site in GtmA [19]. We propose that this region controls
the entry of SAM into, and the exit of SAH from, the active
site of GtmA, and shapes the active site for substrate binding
and catalysis. Indeed, these structural elements are stabilized
in the GtmA–SAM and GtmA–SAH structures. The GtmA–
SAH structure reveals a well-shaped hydrophobic cavity
close to SAH, which probably represents the binding pocket.
As described previously, residues Met10, Phe11, Ser131,
His189, Tyr237 and Lys241 restrict access to the active site in
this structure [19]. Based on molecular docking and an SAH-
bound structure, Duell et al. [19] proposed that the second
dithiol gliotoxin methylation occurs before the monoalkylated
intermediate is released from the GtmA active site. However, a
combination of our structural and RP-HPLC assay data
strongly suggests that GtmA releases MmGT before proceed-
ing to the second methylation step. This seems required,
because access to the active site is restricted for both gliotoxin
and SAH in the GtmA–SAH structure, suggesting that the
binding pocket must be disrupted following the first methyl-
transfer to release MmGT. The recruitment of another SAM
molecule then renders GtmA ready for the second round of
methylation, leading to BmGT generation. Our GtmA–SAM
structure provides evidence that SAM binding occurs in a
structural intermediate state, where the putative gliotoxin
and SAM binding pockets are open due to a dramatic move-
ment of the lower domain and helix a1 (figure 2a,b). A
characteristic of this intermediate is the finding that SAM
binds in a solvent-exposed position, whereas SAH is almost
completely buried in the SAH complex, which corroborates
the hypothesis that the GtmA–SAM structure represents a
conformation involved in SAM loading.
SAH has been shown to be a potent feedback inhibitor
of SAM-dependent methyltransferases [32]. Interestingly, this
inhibition does not occur for GtmA, which appears to be
resistant to SAH-mediated inhibition. This is probably conse-
quential to GtmA-mediated catalytic transfer of two methyl
groups, which means that if SAH was capable of inhibiting
the enzyme, this would affect its ability to rapidly bind a
second SAM molecule for the second methyltransfer of
MmGT. Similarly, the plantazolicin N-methyltransferase
BamL, which dimethylates the N-terminus of this antibiotic,
is also resistant to SAH by-product inhibition [33].
Disrupting the gliotoxin bis-thiomethylation ability of
A. fumigatus did not increase the sensitivity of this organism
to gliotoxin [12]. However, DgliT::DgtmA is more sensitive to
exogenous gliotoxin in comparison with A. fumigatus DgliT or
DgtmA. In addition, DgliA::DgtmA was shown to be signifi-
cantly more sensitive to gliotoxin than DgliA. This implies
that GliT activity effectively compensates for the absence of
GtmA in A. fumigatus DgtmA and that GtmA may have been
an ancestral protective strategy against gliotoxin and/or
other ETPs prior to the acquisition of the gliotoxin cluster by
this organism. The presence of MT-II in non-ETP producing
A. niger supports this hypothesis as MT-II has been shown to
be involved in protection against gliotoxin and possibly other
rsob.royalsocietypublishing.org
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9ETPs [15]. Subsequent redundancy of this superseded protec-
tion mechanism in A. fumigatus may have resulted in the
neofunctionalization of GtmA and its interlinked association
with the gliotoxin biosynthetic gene cluster.
DgliT produces significantly more BmGT than wild-type or
DgliA following exogenous gliotoxin exposure [24]. This
suggested that the inability to oxidize dithiol gliotoxin to glio-
toxin by GliT results in a higher substrate availability for
GtmA. The severe SAM depletion noted in DgliT following glio-
toxin exposure was alleviated in the double deletion mutant
DgliT::DgtmA. Aspergillus fumigatus DgliA::DgtmA was also
found to exhibit higher levels of cellular SAM thanDgliA follow-
ing gliotoxin exposure. Overall, these observations establish a
direct link between the depletion of cellular SAMupon gliotoxin
exposure and gliotoxin bis-thiomethylation mediated by GtmA.
This result also highlights the complexity of the A. fumigatus
response to this toxin. Considering the metabolic expense of
bis-thiomethylation on SAM depletion in A. fumigatus DgliT
and the fast, reversible nature of GliT-mediated dithiol gliotoxin
oxidation, it is understandable that the process of dithiol bis-thio-
methylation may have been relegated to a backup strategy in
A. fumigatus.
Based on the significantly lower concentration of gliotoxin
detected in the culture supernatants of DgliT::DgtmA exposed
to gliotoxin, we hypothesize that following gliotoxin exposure,
DgliT::DgtmA accumulates high levels of intracellular dithiol
gliotoxin which cannot exit the cell by either oxidation (GliT)
and subsequent efflux by GliA, or by GtmA-mediated
bis-thiomethylation. This hypothesis is supported by the
RP-HPLC-based gliotoxin uptake/efflux investigation. The
gliotoxin sensitivity of A. fumigatus mutants is most significant
where the removal of intracellular gliotoxin [12] is hampered
by a combined deficit of the inability to oxidize, efflux or
bis-thiomethylate this metabolite. DgliT::DgtmA was shown to
have the lowest levels of extracellular gliotoxin present following
3 h gliotoxin exposure, which is in complete agreement with the
inability of this mutant to directly dissipate any dithiol gliotoxin
which enters the cell.
Considering that gliotoxin exposure results in the induction
of gli-cluster expression [34] (possibly by intracellular accumu-
lation), the heightened sensitivity of DgliT::DgtmAmay also be
the result of the over-activation of the gli-cluster leading to a
sustained abundance of cognate enzymes. Relevantly, upon
exposure to gliotoxin, five gliotoxin biosynthetic enzymes
(GliG, GliN, GliH, GliM and GliP) were found to be highly
abundant in DgliT::DgtmA compared with DgliT. Thus, it is
plausible that the gliotoxin pathway could proceed to the
penultimate step (dithiol gliotoxin) before being trapped in
the cell owing to the absence of both GliT and GtmA. It is
likely that this in vivo-produced dithiol gliotoxin contributes
to cellular oxidative stress in conjunction with the exogenously
added gliotoxin, which, following uptake, undergoes intra-
cellular GSH-mediated reduction, hampering its export from
the cell (figure 6).
Gliotoxin may act as a specific elicitor of secondary metab-
olism as shown in other systems, but the chemical and
molecular complexity of these induction processes means
that the precise mechanism of activation is poorly understood.
Sixteen of the 95 proteins significantly altered in abundance in
DgliT::DgtmA exposed to gliotoxin are uncharacterized, five of
which (AFUA_1G11120, AFUA_1G11780, AFUA_1G14500,
AFUA_1G15260 and AFUA_5G06370) have no conserved
domains or motif hits. AfuVipB, a putative H3-K9-specifichistone methyltransferase, was significantly downregulated
in DgliT::DgtmA exposed to gliotoxin (AFUA_3G14920; 
21.4122). Induction of the orsellinic acid gene cluster in
A. nidulans by the bacterium Streptomyces rapamycinicus was
shown to be dependent on the Saga/Ada complex containing
the histone acetyltransferase proteins GcnE andAdaB. A Saga/
Ada-dependent increase of histone 3 acetylation at lysine 9 and
14 was shown to occur during this interaction between the
fungus and bacterium. However, the exact nature of the bac-
terial signal remains to be elucidated [36]. It is conceivable
that gliotoxin-mediated induction of the A. fumigatus
gli-cluster may occur through a related mechanism.
Considering the ability of ETP toxins to rapidly generate
deleterious reactive oxygen species within the cell it may be
an evolutionary adaptation of ETP exposed organisms to
disable ETPs with a rapid, single S-methylation instead of
holding the substrate for bis-thiomethylation. Processively
modifying both thiols on the same ETP molecule could be
seen as a disadvantage in this scenario. In fact, epimonothiodi-
ketopiperazine derivatives have been reported to be at least one
order of magnitude less active than their disulfide forms [7].
This reactionmechanismmay also facilitate amore generalized
defence against a variety of thiol-containing natural products.
Detailed analysis of GtmA, the SAM-dependent gliotoxin
bis-thiomethyltransferase that negatively regulates glio-
toxin biosynthesis, reveals extensive structural rearrangement
upon cofactor binding, which provides new insights into the
functionality of this enzyme class. Complete disruption of
self-protection and negative regulatory systems, respectively,
significantly augment hypersensitivity to gliotoxin in
A. fumigatus owing to dysregulated gli-cluster activity, dithiol
gliotoxin biosynthesis and extensive compensatory proteomic
remodelling. We conclude that bis-thiomethylation, an ances-
tral protection system against redox-active metabolites, has
undergone functional evolution.4. Material and methods
4.1. Protein expression
Expression plasmids pEX-N-GST-GtmA (OriGene) and
pET19 m-GtmA (modified pET19b, Novagen) were freshly
transformed into chemically competent Escherichia coli BL21
(DE3) cells and subsequently used for pre-culture inoculation
in lysogenic broth (LB) supplemented with 100 mg l21 ampicil-
lin. Large-scale production of the native protein was carried out
in terrific broth including the required antibiotics. Cells were
incubated at 378C and 120 rpm until optical density reached
0.6–0.8 followed by a temperature reduction to 208C. The
induction of heterologous gene expression was performed by
incubating with 500 mM IPTG for another 20 h. Cells were
collected by centrifugation at 5000 g for 10 min.
L-seleno-methionine-labelled GtmA was produced by
using minimal medium (M9) as described elsewhere [37]. The
LB pre-culture containing pEX-N-GST-GtmA E. coli BL21
(DE3) was centrifuged and washed twice with M9 minimal
medium before inoculation of a larger culture in M9 medium
with corresponding antibiotics at 378C and 120 rpm. An
amino acid cocktail comprising 100 mg l21 lysine, 100 mg l21
phenylalanine, 100 mg l21 threonine, 50 mg l21 isoleucine,
50 mg l21 leucine and 50 mg l21 valine was added to the cell
suspension to suppress methionine biosynthesis when the
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Figure 6. (a) Aspergillus fumigatus DgliT responds to exogenous gliotoxin by effecting excessive bis-thiomethylation on this metabolite, resulting in cellular SAM
depletion. (b) The highly sensitive A. fumigatus DgliT::DgtmA cannot remove intracellular accumulated dithiol gliotoxin by S-methylation [6,35] or oxidation. This
results in cell death as a result of the combined effect of gliotoxin toxicity and gli-cluster over-activation owing to the sustained presence of dithiol gliotoxin.
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10optical density at 600 nm reached 0.5. After an additional
15 min incubation 60 mg l21 L-seleno-methionine and 500 mM
IPTG were added to the cells and the culture was further
incubated at 208C for 20 h.
4.2. Protein purification
The cells were diluted with lysis buffer (50 mM Na2HPO4 pH
8.0; 300 mM NaCl; 5 mM imidazole, 1 mM PMSF, 1 mg ml21
pepstatin A and 300 mM lysozyme), subsequently lysed using
an EmulsiFlex-C3 homogenizer (AVESTIN) and centrifuged
for 30 min at 30 000g and 48C. The resulting supernatant
was applied onto a HisTrap chelating column (GE Healthcare
Life Science) loaded with 100 mM nickel sulfate equilibrated
in buffer A (50 mM Na2HPO4 pH 8.0, 300 mM NaCl, 5 mM
imidazole). Contaminating proteins were washed from thecolumn with buffer A until absorption at 280 nm reached
the baseline. Elution of GtmA was performed by using a
linear gradient over 20 column volumes (CV) to a final
concentration of 100% buffer B (buffer Awith 200 mM imida-
zole). To remove the affinity tag, TEV-protease cleavage was
carried out with a 1 : 40 molar ratio (protease to protein)
overnight at 48C during dialysis against buffer C (50 mM
Tris–HCl pH 7.4; 50 mM NaCl). The cleaved GtmA was
separated from the protease and the affinity tag with a
second nickel-loaded HisTrap chelating column (GE Health-
care Life Science) using buffer C and buffer D (buffer C with
200 mM imidazole). The flow through was collected, concen-
trated and applied to an S200 26/60 size exclusion column
(GE Healthcare Life Science) equilibrated with buffer C. Pure
protein fractions were collected, concentrated to 20 mg ml21
and flash frozen until needed for further experiments.
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11The L-seleno-methionine-labelled GtmAwas purified as an
N-terminally GST-tagged fusion protein as described else-
where [12]. An additional ion exchange chromatography step
using aQ-Sepharose column (GEHealthcare Life Science) equi-
librated in buffer ‘low salt’ (20 mM Tris–HCl pH 8.5, 20 mM
NaCl) was used to separate the TEV protease and residual
GST fromGtmA. Elutionwas carried outwith a linear gradient
over 32 CV and a final concentration of 1 M NaCl using buffer
‘high salt’ (buffer ‘low salt’ with 1 M NaCl). Fractions contain-
ing L-seleno-methionine-labelled GtmA were collected and
applied to an S200 26/60 size exclusion column equilibrated
with buffer C as a final purification step.
4.3. Site-directed mutagenesis of gtmA
The pET19m_GtmAvector served as a template for in vitro site-
directed mutagenesis using the QuikChange XL Site-Directed
Mutagenesis Kit (Stratagene) and the oligonucleotides used are
listed in electronic supplementary material, table S4. Muta-
genesis was carried out as stated in the supplied protocol.
Hereby, the plasmids pET19m_GtmA_W157V, pET19m_
GtmA_W162V, pET19m_GtmA_N159V, pET19m_GtmA_F185G
and pET19m_GtmA_F127V were created. The resulting
plasmids were propagated in E. coli DH5a cells. The DNA
sequence was verified by sequencing, and the vectors were
introduced intoE. coliBL21 (DE3) cells for protein overproduction.
4.4. Methyltransferase assay of GtmA mutants using
RP-HPLC
GtmA methyltransferase activity of the wild-type GtmA and
mutants was monitored by RP-HPLC in 50 mM Tris–HCl,
50 mM NaCl, pH 7.4 using 750 mM SAM and 300 mM dithiol
gliotoxin. 1 mMof purified enzymewas added to each reaction.
The samples were incubated at 378C for 1 h prior to RP-HPLC
analysis. For GtmA activity analysis under SAM limiting con-
ditions, a range of SAM concentrations between 100 and
400 mM were used. For these experiments, reaction mixtures
were directly injected onto the RP-HPLC column without
quenching in order to ensure that enzyme-bound gliotoxin-
ligands were not released. For Km determination, substrates
(either dithiol gliotoxin or MmGT) from 31.25–750 mM were
separately combined with SAM (1.5 mM) and mixed at 378C,
in duplicate. GtmA (10 mM final) was added and mixed
rapidly, and reactions were stopped after 15 s by addition of
TCA to 15% (w/v). Samples were incubated on ice for 20 min,
centrifuged to remove precipitated protein and analysed by
RP-HPLC with detection at 254 nm. Km and nonlinear curve
determination was done using GraphPad PRISM.
4.5. Crystallization, data collection and refinement
Crystal screening was carried out with an automated crystalli-
zation robot (Zinsser Analytic) by using the sitting drop
vapour diffusion method and mixing 0.2 ml protein and
0.2 ml reservoir solution at 208C and 48C. Well diffracting
protein crystals of apo-GtmA were obtained by mixing
15 mg ml21 protein with reservoir containing 0.2 M sodium
formate and 20% (w/v) PEG 3350 at 48C, whereas the
L-seleno-methionine-labelled protein crystallized in reservoir
comprising 0.2 M calcium acetate hydrate and 20% (w/v)
PEG 3350 at a concentration of 15 mg ml21 and 208C. Crystalsof the SAH and SAM complex were achieved by incubation of
15 mg ml21 GtmA with 0.5 mM SAH and 12.5 mM SAM for
30 min before mixing with 2.4 M (NH4)2SO4, 0.1 M MES pH
6.0 and 0.2 M sodium chloride, 0.1 M sodiumphosphate citrate
pH 4.2, 22.3% (w/v) PEG 8000, 0.08% (w/v) ellipticine, 0.20%
(w/v) gibberellin A3, 0.20% (w/v) trans-cinnamic acid, 0.20%
(w/v) phenol, 0.20% (w/v) succinic acid disodium salt hexahy-
drate and 0.02 MHEPES pH 6.8, respectively. The SAM-GtmA
crystal was further soaked with 100 mM Yb-DO3A (Lantha-
nide Phasing Kit, Jena Bioscience) for 10 s. All crystals were
cryo-protected by using 10% (w/v) glycerol. Diffraction data
of the L-seleno-methionine-labelled GtmA were collected on
beamline BL14.2 operated by the Helmholtz-Zentrum Berlin
at the BESSY II electron storage ring (Berlin-Adlershof,
Germany) [38], of the apo GtmA and the SAH complex on
beamline ID 30B at European Synchrotron Radiation Facility
(Grenoble, France) [39] and of the SAM complex on beamline
P11 at DESY, PetraIII (Hamburg, Germany) [40]. Single anom-
alous diffraction data of the L-seleno-methionine-labelled
GtmA and of the Yb-soaked SAM complex were collected at
a wavelength of 0.9798 A˚ and 1.3855 A˚, whereas native data
of apo GtmA and the SAH complex were collected at 0.9762
A˚. All diffraction data were indexed and integrated with XDS
[41] and scaled with AIMLESS from the CCP4 package [42].
For the Se-SAD data, the AUTOSOL [43,44] routine of the
PHENIX software suite [43] was used to generate experimental
phases and to build the structure. The resultingmodelwas used
for rigid body refinement in phenix.refine to solve the structure
of native GtmA. The SAM complex structure was solved with
MR-Yb-SAD by using the apo structure as model in PHASER
[43,45], built with AUTOBUILD [43,46] and finally used to
solve the SAH complex with PHASER [45]. All structures
have been refined using alternating steps ofmanual adjustment
in COOT [47] and maximum-likelihood refinement in PHENIX
[43], and finally validated by using MOLPROBITY [48].
Coordinates and diffraction data have been deposited in
the Protein Data Bank [49] with accession codes 5JGJ, 5JGK
and 5JGL for the GtmA-apo, SAH and SAM complexes,
respectively.4.6. Microscale thermophoresis
To determine the binding affinity between GtmA and SAM or
SAH, MST was used [50]. For this, GtmA was labelled with
Cy5 Mono NHS Ester (Amersham) according to the vendor’s
manual. To determine KD-values for SAM and SAH, a fixed
concentration of 100 nM GtmA-Cy5 was titrated with serial
1 : 1 dilutions of both ligands in labelling buffer (50 mM Tris,
50 mM NaCl, pH 7.4, 0.5 mg ml21 bovine serum albumin). In
order to determine KD-values for GtmA and SAM under oxi-
dizing and reducing conditions, 10 mM oxidized glutathione
(GSSG; oxidizing conditions) or 10 mM TCEP (Tris(2-carbox-
yethyl)phosphine, reducing conditions) was added to the
labelling buffer. The experiments were performed using a
NanoTemper Monolith NT.115 instrument with standard (for
non-binding molecules) capillaries at 228C, 20% LED power
and 40% MST power. For KD determination, experiments
were executed in triplicate. The response value was averaged
and plotted against the concentration of the ligands. KD
values were extracted by fitting to the quadratic equation
(4.1), using the vendor’s software (KD fitted in MO.Affinity
rsob.royalsocietypublishing.org
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12Analysis software, NANOTEMPER).
FðCTÞ ¼ FA þ FAT  FA2CA ðCT þ CA þ KD

ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
ðCT þ CA þ KDÞ  4CTCA
p
Þ: ð4:1Þ
Here, FA represents the response value of unbound
labelled molecules, FAT the response value of the complex
of labelled and the unlabelled ligand molecules, CA the con-
centration of labelled molecule and CT the concentration of
the unlabelled ligand molecule.
4.7. Generation of Aspergillus fumigatus DgliT::DgtmA
and DgliA::DgtmA
Aspergillus fumigatus gtmA double mutants were generated in
the DgliT and DgliA backgrounds via the bipartite marker tech-
nique using the hygromycin (hph) resistance marker for
deletion (electronic supplementarymaterial, experimental pro-
cedures). Primers used for generating all deletion constructs
are given in electronic supplementary material, table S4.
4.8. RP-HPLC and LC–MS detection of natural products
from Aspergillus fumigatus culture supernatants
For gliotoxin spiking experiments, cultures were grown in
Sabouraud–dextrose medium for 21 h followed by gliotoxin
addition (2.5 mg ml21 final) for 3 h (n ¼ 3 biological replicates
for all specimens). All strains used are given in electronic
supplementary material, table S5. Organic extracts from super-
natants were analysed by RP-HPLC with UV detection
(Agilent 1200 system), using a C18 RP-HPLC column (Agilent
Zorbax Eclipse XDB-C18 Semi-Preparative; 5 mm particle size;
4.6  250 mm) at a flow rate of 2 ml min21. A mobile phase
of water and acetonitrile with TFA was used under various
gradient conditions. Aspergillus fumigatus wild-type, deletion
and complementation strains were grown for 72 h in Czapek
Dox medium (unless stated otherwise) followed by organic
extraction and LC–MS analysis as previously described [12].
Supernatants were diluted 1/10 in 0.1% (v/v) formic acid
and spin filtered prior to LC–MS analysis (Agilent Ion Trap
6340) to detect BmGT presence. Gliotoxin (purity: 98%) and
BmGT (purity: 99%) standards were obtained from Sigma-
Aldrich and Enzo Life Sciences, respectively.
4.9. Aspergillus fumigatus phenotypic assays
Aspergillus fumigatuswild-type andmutant strainswere grown
on MEA agar for 5 days at 378C after which conidia were har-
vested. Conidia were serially diluted to 1022 and 1024 in PBS.
Aliquots (5 ml) of each dilution were spotted onto agar plates
containing gliotoxin. Plates were incubated at 378C and
growth was monitored at specific time intervals by measuring
the diameter of radial growth (cm) of each colony. Two-way
ANOVA analysis was performed to determine the statistical
significance between strains on the various additives.
4.10. Detection and quantification of S-
adenosylmethionine
Czapek Dox medium was inoculated with 106 ml21 conidia
(from A. fumigatus wild-type, gene deletion andcomplementation strains), in triplicate, and incubated at 378C,
shaking 200 rpm, for 21 h. Gliotoxin (5 mg ml21 final) or metha-
nol control was added and the cultures were incubated for a
further 3 h before mycelia were harvested and snap frozen in
liquid N2. SAM was extracted using a modified protocol as
described previously [24]. Briefly, mycelia were ground under
liquid N2 using a pestle and mortar. 0.1 M HCl (250 ml) was
added to mycelia (100 mg) and incubated on ice for 1 h with
regular vortexing. Following centrifugation at 13 000g, protein
was removed from the supernatant by TCA precipitation.
Samples were diluted in 0.1% (v/v) formic acid and analysed
by LC–MS/MS using a porous-graphitized carbon chip on
an Agilent 6340 ion-trap LC mass spectrometer (Agilent
Technologies) using electrospray ionization.
4.11. Comparative quantitative proteomic analysis of
Aspergillus fumigatus wild-type and mutant
strains
Aspergillus fumigatus wild-type (ATCC26933), DgtmA and
DgliT strains were cultured in Sabouraud–dextrose medium
for 21 h followed by gliotoxin (2.5 mg ml21 final) or methanol
addition for 3 h (n ¼ 3 biological replicates for all specimens).
Mycelia were then harvested and snap frozen in liquid N2.
Mycelial lysateswereprepared in lysis buffer (100 mMTris–
HCl, 50 mM NaCl, 20 mM EDTA, 10% (v/v) glycerol, 1 mM
PMSF, 1 mg ml21 pepstatin A, pH 7.5)with grinding, sonication
and clarified using centrifugation. The resultant protein lysates
were precipitated using trichloroacetic acid/acetone and resus-
pended in 100 mM Tris–HCl, 6 M urea, 2 M thiourea, pH 8.0.
After dithiothreitol reduction and iodoacetamide-mediated
alkylation, sequencing grade trypsin combined with Protease-
Max surfactant was added [51]. All peptide mixtures were
analysed via a Thermo Fisher Q-Exactive mass spectrometer
coupled to a Dionex RSLCnano. LC gradients ran from 4% to
35% B over 2 h, and data were collected using a Top15
method for MS/MS scans. Comparative proteome abundance
and data analysis was performed using MAXQUANT software
(v. 1.3.0.5) [52], with ANDROMEDA used for database searching
and PERSEUS used to organize the data (v. 1.4.1.3) [12].
4.12. Analysis of Aspergillus fumigatus DgtmA::gtmA-
eGFP::H2A::mRFP 26933 by confocal microscopy
The gtmA-eGFP strain transformed with H2A::mRFP (1  104
conidia) was inoculated into 400 ml Czapek Dox medium in a
Lab-Tekchamberedborosilicatecoverglasssystem.Thechamber
was incubated at 378C for 21 h and then gliotoxin (5 mg ml21
final) was added to the chambers. An equivalent volume of
methanol was added to the control wells. As a second control a
well containing DgtmA with gliotoxin was also prepared.
Samples were incubated at 378C for 3 h. Samples were viewed
with anOlympus Fluoview 1000 confocal microscope.
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